Cargando…

Vaccine hesitancy against COVID-19 vaccine over time in Nigeria

INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This stu...

Descripción completa

Detalles Bibliográficos
Autor principal: Sato, Ryoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028343/
https://www.ncbi.nlm.nih.gov/pubmed/36959055
http://dx.doi.org/10.1016/j.vaccine.2023.03.029
_version_ 1784909930120085504
author Sato, Ryoko
author_facet Sato, Ryoko
author_sort Sato, Ryoko
collection PubMed
description INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This study examined the extent and trend of vaccine hesitancy in Nigeria. METHODS: The COVID-19 National Longitudinal Phone Survey conducted between 2020 and 2021 was used for the analysis. The extent and trend of vaccine hesitancy across different zones within Nigeria, over time, as well as reasons of the hesitancy were evaluated. RESULTS: Vaccine hesitancy was more prevalent in southern zones, which on average have better socioeconomic status than northern zones. Overtime, vaccine hesitancy became more prevalent, and respondents became more resistant to the COVID-19 vaccine across the country. CONCLUSION: While the nature of interventions to improve the uptake of COVID-19 vaccine should differ by regions due to differential barriers to vaccination, it might be important to prebunk and debunk any misinformation related to COVID-19 vaccine to mitigate the vaccine hesitancy across the country.
format Online
Article
Text
id pubmed-10028343
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100283432023-03-21 Vaccine hesitancy against COVID-19 vaccine over time in Nigeria Sato, Ryoko Vaccine Short Communication INTRODUCTION: While COVID-19 pandemic is an ongoing threat for our lives, the rapid development of effective vaccines against COVID-19 provided us hopes for manageable disease control. However, vaccine hesitancy across the globe is a concern which could attenuate efforts of disease control. This study examined the extent and trend of vaccine hesitancy in Nigeria. METHODS: The COVID-19 National Longitudinal Phone Survey conducted between 2020 and 2021 was used for the analysis. The extent and trend of vaccine hesitancy across different zones within Nigeria, over time, as well as reasons of the hesitancy were evaluated. RESULTS: Vaccine hesitancy was more prevalent in southern zones, which on average have better socioeconomic status than northern zones. Overtime, vaccine hesitancy became more prevalent, and respondents became more resistant to the COVID-19 vaccine across the country. CONCLUSION: While the nature of interventions to improve the uptake of COVID-19 vaccine should differ by regions due to differential barriers to vaccination, it might be important to prebunk and debunk any misinformation related to COVID-19 vaccine to mitigate the vaccine hesitancy across the country. Elsevier Ltd. 2023-04-24 2023-03-21 /pmc/articles/PMC10028343/ /pubmed/36959055 http://dx.doi.org/10.1016/j.vaccine.2023.03.029 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Sato, Ryoko
Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title_full Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title_fullStr Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title_full_unstemmed Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title_short Vaccine hesitancy against COVID-19 vaccine over time in Nigeria
title_sort vaccine hesitancy against covid-19 vaccine over time in nigeria
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028343/
https://www.ncbi.nlm.nih.gov/pubmed/36959055
http://dx.doi.org/10.1016/j.vaccine.2023.03.029
work_keys_str_mv AT satoryoko vaccinehesitancyagainstcovid19vaccineovertimeinnigeria